Syntekabio Inc.’s Post

Are you in the early drug discovery field? We've got something special coming your way... We are organising a series of digital events with experienced speakers from the lab automation and biotech industries. We would like to know which topics interest you the most 🤔 Your input is valuable, and we're eager to tailor our content to your preferences. Please drop your thoughts in the comments 👇 #BioTechnology #DrugDiscovery #Pharma

💡 𝐅𝐚𝐜𝐢𝐧𝐠 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐢𝐧 𝐨𝐩𝐭𝐢𝐦𝐢𝐳𝐢𝐧𝐠 𝐝𝐫𝐮𝐠 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐩𝐫𝐨𝐜𝐞𝐬𝐬𝐞𝐬? AI has the power to revolutionize the way generics are developed, making them #faster, more #efficient, and cost #effective. Join our 𝐅𝐑𝐄𝐄 𝐰𝐞𝐛𝐢𝐧𝐚𝐫 on S̳e̳p̳t̳e̳m̳b̳e̳r̳ ̳2̳7̳t̳h̳ to unlock #insights into how AI and in silico modeling are reshaping generic drug development. Don't miss out on key #industry trends and #strategies to stay ahead! ✨ 🔗 𝘙𝘦𝘨𝘪𝘴𝘵𝘦𝘳 𝘕𝘰𝘸: https://lnkd.in/gxfXp7S6 📱 Scan the QR Code for easy registration! 𝑳𝒆𝒂𝒓𝒏 𝒉𝒐𝒘 𝒕𝒐 𝒕𝒓𝒂𝒏𝒔𝒇𝒐𝒓𝒎 𝒚𝒐𝒖𝒓 𝒅𝒓𝒖𝒈 𝒅𝒆𝒗𝒆𝒍𝒐𝒑𝒎𝒆𝒏𝒕 𝒆𝒇𝒇𝒐𝒓𝒕𝒔 𝒘𝒊𝒕𝒉 𝒄𝒖𝒕𝒕𝒊𝒏𝒈-𝒆𝒅𝒈𝒆 𝑨𝑰. 𝑺𝒆𝒂𝒕𝒔 𝒂𝒓𝒆 𝒇𝒊𝒍𝒍𝒊𝒏𝒈 𝒖𝒑 𝒇𝒂𝒔𝒕—𝒓𝒆𝒔𝒆𝒓𝒗𝒆 𝒚𝒐𝒖𝒓𝒔 𝒕𝒐𝒅𝒂𝒚! #Webinar #pharma #drugdevelopment #ModelingAndSimulation #RegulatoryAffairs #Biosimilars #Generics #InSilico #biotechnology #LifeSciences #freewebinar InSilicoTrials

Lab automation is not just about technology; it's about the impact on healthcare, drug discovery, and beyond. On International LabAutomation Day, let's reflect on how automation accelerates us toward a healthier future. To learn more: labautomationday.lrig.org #ImpactfulInnovation #InternationalLabAutomationDay #LabAutomationDay #LRIG #LabAutomation #LaboratoryAutomation #LaboratoryRobotics #LabRobotics #LabRobot #Automation #SampleManagement #CompoundManagement #LiquidHandling #HighThroughputScreening #HTS #SyntheticBiology #synbio #DrugDiscovery #HighContentScreening #Biobanking #Biospecimen #Biorepository #Biobank #CRISPR #CellCulture

In the latest newseltter, Andrii Buvailo, Ph.D. discusses the hype around the AlphaFold 3 launch, what is real, and what is still an overestimation. Also, there are 4 companies developing AI-driven platforms for novel therapeutic modalities and even entire classes of drugs. Read the newsletter following a link in the comments 👇 #biopharmatrend #biotech #drugdiscovery #WhereTechMeetsBio

I am excited to share that I recently attend the digital modules of One Day International workshop on Al and Machine Learning For Drug Discovery. our sessioned expert share valuable insights garnered from extensive experience in the field. #AIforDrugDiscovery #MachineLearning #DrugDiscovery #Pharma #Biotech #Research #Workshop #Innovation"

Is data drought holding back your orphan drug? When it comes to the development and launch of orphan drugs, the natural scarcity of clinical trial data can present a barrier for biotech companies to overcome. The potential impact of innovative new treatments is often restricted. In our latest article, we explore how gathering real-world observational data can help drive your product forward in Europe and ensure it reaches its potential. Learn more at: https://lnkd.in/eAYNcZcD #OrphanDrugs #Biotech #RealWorldData #ClinicalTrials

Biotech Summit Austria has started with a "hike and dine" to the beautiful Umbrüggler Alm. Already had some insightful conversations along the way while enjoying stunning views of the Alps. Excited about the two more days of presentations and productive discussions on the state of the art in biotech! If you're interested in learning how Aliri Bioanalysis can generate vital results across your non-clinical and clinical stages to drive your candidate forward - dm and let's chat in the breaks😊 #drugdevelopment #bioanalytics #biotech #pharma

The speaker's lineup is strong, and the topics are very relevant to the industry. I will talk about #AI and #precisionmedicine. I hope to see you there! Please notice that you can use the speaker discount code. #rwe #marketaccess #innovation #pharma #biotech #medtech #medicalaffairs #aiinmedicine

Discover the power of #NaturalProducts in drug innovation! While traditional modification can be lengthy & costly with multifaceted protein interactions, a paradigm shift is underway. Leveraging #ChemicalProteomics techniques, we're now streamlining target identification in NPs. This strategic approach yields comprehensive profiles of bioactive small molecules engaging with proteins - the two pivotal stages: probe design/synthesis and meticulous target validation. Contact us to redefine NP-based drug development！！ 💭

Join me and my @Eliassen Group colleagues at @DIA 2024 in booth #1530. I look forward to seeing you!   @brandon pallot @peggy murray @nicole legler @veronica onesi @patrick hurley   #DIA2024 #BioPharma #BioTech #LifeSciences #Regulatory #ClinicalResearch #ClinicalOperations #ClinicalDataSciences #AI